Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.56 |
| ▸ | ULK1 | O75385 | 1/20 | 0.52 |
| ▸ | KHK | P50053 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | TERT | O14746 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.49 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.48 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | HTR1E | P28566 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10913060 | 1.00 | CYP1A2 (0.58) | CYP1A2RECQLPSMB8ULK1KHK | |
| SCHEMBL29757656 | 1.00 | CYP1A2 (0.58) | CYP1A2RECQLPSMB8ULK1KHK | |
| SCHEMBL2293435 | 1.00 | CYP1A2 (0.58) | CYP1A2RECQLPSMB8ULK1KHK | |
| Hydrochloric Acid SCHEMBL28580045 | 0.99 | CYP1A2 (0.56) | CYP1A2RECQLPSMB8ULK1KHK | |
| SCHEMBL23373324 | 0.87 | PFKFB3 (0.59) | MEN1KMT2AMAPTL3MBTL1LMNA | |
| SCHEMBL3341023 | 0.82 | NPC1 (0.58) | CYP1A2PSMB8ULK1MEN1KMT2A | |
| SCHEMBL3343865 | 0.82 | NPC1 (0.58) | CYP1A2PSMB8ULK1MEN1KMT2A | |
| SCHEMBL3341031 | 0.82 | NPC1 (0.58) | CYP1A2PSMB8ULK1MEN1KMT2A | |
| SCHEMBL2172641 | 0.82 | HPGD (0.56) | CYP1A2PSMB8ULK1KHKMEN1 | |
| SCHEMBL2392383 | 0.82 | HPGD (0.56) | CYP1A2PSMB8ULK1KHKMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230114304-A1 | DEPALMITOYLATING COMPOSITIONS AND THE USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-04-13 | — | — | US | disclosed |
| EP-4013498-A1 | DEPALMITOYLATING COMPOSITIONS AND THE USE THEREOF | The Regents of the University of California (US) | 2022-06-22 | — | — | EP | disclosed |
| WO-2021030703-A1 | DEPALMITOYLATING COMPOSITIONS AND THE USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-02-18 | — | — | WO | disclosed |
| CN-109652343-A | It is a kind of degrade hexabromocyclododecane bacterial strain screening method and its application | 上海交通大学 | 2019-04-19 | — | — | CN | disclosed |
| US-8217204-B2 | Catalyst for asymmetric hydrogenation | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20100324338-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-12-23 | — | — | US | disclosed |
| WO-2010140636-A1 | ASYMMETRIC HYDROGENATION CATALYST | 高砂香料工業株式会社 (JP) | 2010-12-09 | — | — | WO | disclosed |
| CN-1558947-A | Gene of peptide-producing enzyme, and process for producing dipeptide | ֮����ʽ���� | 2004-12-29 | — | — | CN | disclosed |
| US-6596898-B2 | Making a 2-fluoro-2-chlorocyclopropanecarboxylic acid derivative stereoselectively in high yield by reacting a diazoacetic acid derivative with 1-fluoro-1-chloroethylene using metal catalyst having chiral ligands | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2003-07-22 | — | — | US | disclosed |
| US-20010051750-A1 | PROCESS FOR PREPARING HALOGENATED CYCLOPROPANE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2001-12-13 | — | — | US | disclosed |
| EP-0858992-B1 | PROCESS FOR PRODUCING HALOGENATED CYCLOPROPANE DERIVATIVES | DAIICHI SEIYAKU CO (JP) | 2001-12-12 | — | — | EP | disclosed |
| EP-0858992-A1 | PROCESS FOR PRODUCING HALOGENATED CYCLOPROPANE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1998-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324338-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION | H1-0, H1-5, ADH5 | CYP1A2 1183/4885RECQL 4078/4885PSMB8 3775/4885 |
| US-20230114304-A1 | DEPALMITOYLATING COMPOSITIONS AND THE USE THEREOF | LIPA, LCAT, SGMS2 | CYP1A2 2732/4885RECQL 2019/4885PSMB8 2189/4885 |
| US-20010051750-A1 | PROCESS FOR PREPARING HALOGENATED CYCLOPROPANE DERIVATIVES | CYP2F1, CYP4F2, CYP4F8 | CYP1A2 26/4885RECQL 3378/4885PSMB8 1493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.